14 November 2024
The information contained
within this announcement is deemed by the Company to constitute
inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014 as amended by the Market Abuse (Amendment) (EU
Exit) Regulations 2019. Upon the publication of this announcement
via the Regulatory Information Service, this inside information is
now considered to be in the public domain.
Inspiration Healthcare Group
plc
("Inspiration Healthcare",
the "Company" or the "Group")
Board
Changes
Inspiration Healthcare Group plc
(AIM: IHC) ("Inspiration Healthcare" or the "Company"), the global
medical technology company, today announces that Mr Brook
Nolson will step down from the role of Chief Operating Officer with
immediate effect to pursue other opportunities.
The Board would like to thank Brook
for his hard work and dedication to the company over the past 12
years and wish him every success in his future
endeavours.
For
further information, please contact:
|
Inspiration Healthcare Group plc
|
Tel: +44 (0)330 175 0000
|
|
Roy Davis, Executive
Chairman
Alan Olby, Chief Financial
Officer
|
|
|
|
|
|
Panmure Liberum (Nominated Adviser &
Broker)
|
Tel: +44 (0)20 3100 2000
|
|
Richard Lindley
Will King
|
|
|
|
|
|
Walbrook PR Ltd (Media and Investor
Relations)
|
Tel: +44
(0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
|
|
Anna Dunphy
|
Mob: +44
(0) 7876 741 001
|
|
Louis Ashe-Jepson
|
Mob: +44
(0) 7747 515 393
|
About Inspiration Healthcare
Inspiration Healthcare (AIM:
IHC) designs, manufactures and markets pioneering medical
technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical
need to help to save the lives and improve the outcomes of
patients, starting with the very first breaths of life.
The Company has a broad portfolio of
its own products and complementary distributed products, for
use in neonatal intensive care designed to support even the most
premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as
ventilators for life support through to single-use
disposables.
The Company sells its products
directly to hospitals and healthcare providers in the UK and
Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy. In the rest of the world
the Company has an established network of distribution partners
around the world giving access to more than 75
countries.
The Company operates in the UK from
its world-class Manufacturing and Technology Centre in Croydon,
South London and in the USA from its facility in Melbourne,
Florida.
Further information on Inspiration
Healthcare can be found at www.inspirationhealthcaregroup.com